Clinical Trial Update: Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial assessing autologous adipose-derived mesenchymal stem cell transplantation for the treatment of hemifacial spasm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemifacial Spasm

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cell transplantation (mesenchymal stem cells (adipose-derived))

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Injury of Facial Nerve, Unspecified Side, Initial Encounter | EARLY_Phase 1 | Status: UNKNOWN